Week in review: Epi-on trial, dry eye drug, gold contacts
- Posted on: Mar 5 2021
- Leave a response
This week, Glaukos’ investigational epi-on CXL therapy shows promise in phase 3 trials, a new dry eye drug shows an excellent safety profile and contacts infused with gold nanoparticles may help manage red-green color blindness.
Source: AAO
Posted in: Uncategorized